- Home
- PRQR vs ALTI Comparison
PRQR vs ALTI Comparison
Compare PRQR & ALTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- ALTI
- Stock Information
- Founded
- PRQR 2012
- ALTI 2020
- Country
- PRQR Netherlands
- ALTI United States
- Employees
- PRQR N/A
- ALTI N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- ALTI Investment Managers
- Sector
- PRQR Health Care
- ALTI Finance
- Exchange
- PRQR Nasdaq
- ALTI Nasdaq
- Market Cap
- PRQR 179.1M
- ALTI 406.5M
- IPO Year
- PRQR 2014
- ALTI N/A
- Fundamental
- Price
- PRQR $2.04
- ALTI $4.13
- Analyst Decision
- PRQR Strong Buy
- ALTI
- Analyst Count
- PRQR 8
- ALTI 0
- Target Price
- PRQR $8.88
- ALTI N/A
- AVG Volume (30 Days)
- PRQR 355.0K
- ALTI 271.0K
- Earning Date
- PRQR 08-07-2025
- ALTI 08-08-2025
- Dividend Yield
- PRQR N/A
- ALTI N/A
- EPS Growth
- PRQR N/A
- ALTI N/A
- EPS
- PRQR N/A
- ALTI N/A
- Revenue
- PRQR $21,212,711.00
- ALTI $214,086,000.00
- Revenue This Year
- PRQR N/A
- ALTI $24.86
- Revenue Next Year
- PRQR N/A
- ALTI $10.74
- P/E Ratio
- PRQR N/A
- ALTI N/A
- Revenue Growth
- PRQR 85.91
- ALTI N/A
- 52 Week Low
- PRQR $1.07
- ALTI $2.33
- 52 Week High
- PRQR $4.62
- ALTI $5.36
- Technical
- Relative Strength Index (RSI)
- PRQR 71.54
- ALTI 71.65
- Support Level
- PRQR $1.89
- ALTI $3.94
- Resistance Level
- PRQR $2.20
- ALTI $4.24
- Average True Range (ATR)
- PRQR 0.11
- ALTI 0.24
- MACD
- PRQR 0.02
- ALTI 0.01
- Stochastic Oscillator
- PRQR 90.70
- ALTI 89.29
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About ALTI AlTi Global Inc.
AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a proven track record with risk adjusted return characteristics.